Antiagregancia a antikoagulancia v prevenci a v léčbě cévních mozkových příhod
| Title in English | Antiplatelet and anticoagulation agents in prevention and therapy of cerebrovascular diseases |
|---|---|
| Authors | |
| Year of publication | 2007 |
| Type | Article in Periodical |
| Magazine / Source | Remedia |
| MU Faculty or unit | |
| Citation | |
| Field | Pharmacology and pharmaceutical chemistry |
| Keywords | cerebral infarction; transitory ischemic attack; dual antiplatelet therapy; anticoagulation therapy |
| Description | The objective of the antiplatelet and anticoagulant therapy is to achieve effective prevention of recurrent cerebral infarction or transitory ischemic attack. Focus is mainly on the recent knowledge of dual antiplatelet therapy and on indications for anticoagulant therapy. The anticoagulant therapy (warfarin) is recommended in patients with cardioembolic stroke. The antiplatelet therapy is given preference in non-cardioembolic stroke. Combination of acetylsalicylic acid with dipyridamole has proven superior to acetylsalicylic acid alone. |